BioSpace News Archive

FDA

Janssen’s Erleada Approved for New Prostate Cancer Indication

Erleada is an androgen receptor inhibitor approved for non-metastatic castration-resistant prostate cancer.

September 18, 2019
·
3 min read
·
Mark Terry
Biotech Beach

New Test (Receptivadx) Brings Hope and New Answers for Unexplained Infertility, Failed IVF and Miscarriage

The receptivadx can have meaningful impact on women struggling with unexplained infertility by giving them an answer to their infertility. Learn more here.

September 18, 2019
·
15 min read
·
Chelsea Weidman Burke
Drug Development

Alzheimer’s Disease Insight Report: Current Therapies, Drug Pipeline and Outlook

50 million people worldwide live with symptomatic Alzheimer’s, which has no cure. In honor of September 21st being World Alzheimer’s Day, we evaluated the current therapies, drugs in the pipeline and disease outlook.

September 18, 2019
·
36 min read
·
Chelsea Weidman Burke, M.S.
BioMidwest

CRISPR Research Might Lead to Cure for Duchenne Muscular Dystrophy

Researchers at the University of Missouri-Columbia, utilized CRISPR gene editing in a mouse model, to edit out the gene mutation and transplant AAV9 treated muscle into the mice.

September 18, 2019
·
3 min read
·
Mark Terry
Deals

Investment Plan for Europe – Successful launch of Tech Transfer Fund “KHAN-I”

Khanu Management GmbH, a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG, based in Dortmund, Germany.

September 18, 2019
·
7 min read
Bio NC

Rho Named to Best Places to Work List by Triangle Business Journal for the Eighth Time

Rho announced that the Triangle Business Journal has named the company a winner of the Best Places to Work award in the Triangle.

September 18, 2019
·
1 min read
Deals

AML biotech Race Oncology (RAC) strengthens board with prominent biotech investor Dr Daniel Tillet

Race Oncology Limited is pleased to announce that prominent biotechnology investor and substantial Race shareholder, Dr Daniel Tillett, has joined the Board of Directors of Race Oncology Ltd.

September 18, 2019
·
2 min read
Drug Development

Nordic Nanovector R&D Day unveils updates on several programmes

Nordic Nanovector ASA (OSE: NANO) will host an R&D day in Oslo.

September 18, 2019
·
8 min read
Eisai Receives IIA Japan Chairman’s Award of Institute of Internal Auditors - Japan

Eisai Co., Ltd. has announced that it received the 33rd “IIA Japan Chairman’s Award” of the Institute of Internal Auditors

September 18, 2019
·
2 min read
FDA

Merck, Eisai Win FDA Approval for Combination Treatment for Advanced Endometrial Carcinoma

The U.S. Food and Drug Administration approved Keytruda in combination with Eisai’s Lenvima for the treatment of patients with advanced endometrial carcinoma.

September 18, 2019
·
2 min read
·
Alex Keown